Trastuzumab Deruxtecan (T-DXd; DS-8201) in HER2-Positive (HER2+) and HER2-Low Expressing (HER-LE) Metastatic Breast Cancer (MBC) with Brain Metastases (BM) and/or Leptomeningeal Carcinomatosis (LMC): DEBBRAH
Trastuzumab Deruxtecan
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Trastuzumab Deruxtecan (T-DXd; DS-8201) in HER2-Positive (HER2+) and HER2-Low Expressing (HER-LE) Metastatic Breast Cancer (MBC) with Brain Metastases (BM) and/or Leptomeningeal Carcinomatosis (LMC): DEBBRAH ### Output: Trastuzumab Deruxtecan